Poliomyelitis
191
6
10
163
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
56 trials with published results (29%)
Research Maturity
163 completed trials (85% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.1%
4 terminated out of 191 trials
97.6%
+11.0% vs benchmark
63%
121 trials in Phase 3/4
34%
56 of 163 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 163 completed trials
Clinical Trials (191)
Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
Effects of Virtual Walking on Chronic Pain and Psychological Distress for Individuals With Severe Mobility Impairment
A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants
A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2
Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
Study of BK1803 in Healthy Infants
A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers
The Impact of 'Digital Strolling' on Depression and Quality of Life of People With Severe Mobility Impairment
Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine
Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations
Booster Dose of sIPV Co-administered With MMR and HepA-I.
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
Confirmatory Study of BK1310 in Healthy Infants
Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)
A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine
High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners
Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines
Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis